These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15822863)

  • 1. [Pharmacodynamics of triptorelin].
    Lahlou N
    Rev Prat; 2005; Spec. No():8-11. PubMed ID: 15822863
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of protocols efficacy in poor responders: differences in oocytes/embryos competence with different protocols, a retrospective study.
    Manno M; Tomei F; Cervi M; Favretti C; Adamo V
    Fertil Steril; 2009 Apr; 91(4 Suppl):1431-3. PubMed ID: 18706554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovulation induced by mucosa vaginal absorption of buserelin and triptorelin in rabbit.
    Viudes-de-Castro MP; Lavara R; Marco-Jiménez F; Cortell C; Vicente JS
    Theriogenology; 2007 Oct; 68(7):1031-6. PubMed ID: 17854884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.
    Hernández ER; Gómez-Palomares JL; Ricciarelli E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1358-61. PubMed ID: 18555236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome.
    Villa P; De Marinis L; Mancini A; Guido M; Selvaggi L; Lanzone A
    Fertil Steril; 2004 Jul; 82(1):250-2. PubMed ID: 15237028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial distribution and activity in human mature oocytes: gonadotropin-releasing hormone agonist versus antagonist for pituitary down-regulation.
    Dell'Aquila ME; Ambruosi B; De Santis T; Cho YS
    Fertil Steril; 2009 Jan; 91(1):249-55. PubMed ID: 18367183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis.
    Loverro G; Carriero C; Rossi AC; Putignano G; Nicolardi V; Selvaggi L
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):194-8. PubMed ID: 17178185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty.
    Poomthavorn P; Khlairit P; Mahachoklertwattana P
    Horm Res; 2009; 72(2):114-9. PubMed ID: 19690429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a GnRH agonist on cryopreserved human ovarian grafts in severe combined immunodeficient mice.
    Maltaris T; Beckmann MW; Binder H; Mueller A; Hoffmann I; Koelbl H; Dittrich R
    Reproduction; 2007 Feb; 133(2):503-9. PubMed ID: 17307918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats.
    Umathe SN; Bhutada PS; Jain NS; Dixit PV; Wanjari MM
    Behav Pharmacol; 2008 Jul; 19(4):308-16. PubMed ID: 18622178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary desensitization for eight weeks after the administration of two distinct gonadotrophin-releasing hormone agonists.
    Matteo M; Caroppo E; Gliozheni O; Carone D; Schonauer LM; Vizziello G; Greco P; D'Amato G
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):77-80. PubMed ID: 16359772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analogues.
    Tornøe CW; Agersø H; Senderovitz T; Nielsen HA; Madsen H; Karlsson MO; Jonsson EN
    Br J Clin Pharmacol; 2007 Jun; 63(6):648-64. PubMed ID: 17096678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptorelin pamoate (Trelstar).
    Med Lett Drugs Ther; 2002 Jun; 44(1132):51-2. PubMed ID: 12058149
    [No Abstract]   [Full Text] [Related]  

  • 15. RETRACTED: Treatment of nonparaphilic hypersexuality in men with a long-acting analog of gonadotropin-releasing hormone.
    Safarinejad MR
    J Sex Med; 2009 Apr; 6(4):1151-1164. PubMed ID: 19138369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leuprorelin, triptorelin: new indications. Locally advanced prostate cancer: minimally assessed me-toos.
    Prescrire Int; 2007 Dec; 16(92):243. PubMed ID: 18092407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precocious puberty in Sanfilippo IIIA disease: diagnosis and follow-up of two new cases.
    Concolino D; Muzzi G; Pisaturo L; Piccirillo A; Di Natale P; Strisciuglio P
    Eur J Med Genet; 2008; 51(5):466-71. PubMed ID: 18586597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes.
    De Falco M; Staibano S; Mascolo M; Mignogna C; Improda L; Ciociola F; Carbone IF; Di Lieto A
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):44-7. PubMed ID: 19297072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction.
    Cerrillo M; Rodríguez S; Mayoral M; Pacheco A; Martínez-Salazar J; Garcia-Velasco JA
    Fertil Steril; 2009 Apr; 91(4 Suppl):1526-8. PubMed ID: 18990367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.